Unità Di Pneumologia E Terapia Semi-Intensiva Respiratoria, Servizio Di Fisiopatologia Respiratoria Ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica IRCCS, Via San Vittore 12, 20123, Milano, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Intern Emerg Med. 2022 Sep;17(6):1679-1687. doi: 10.1007/s11739-022-02985-z. Epub 2022 May 20.
During the Coronavirus-19 pandemic, chest X-ray scoring system have been validated by Al-Smadi and Toussie in this group of patients and even RALE score, previously designed for ARDS, have been used to estimate correlation with mortality. The aim of this study was to evaluate the prognostic value of As-Smadi, Tuossie and RALE scores in predicting death in the same population of patients when associated to clinical data. In this retrospective clinical study, data of patients with COVID-19, admitted to our hospital from 1st October 2020 to 31st December 2020 were collected. CXR images of each patient were analyzed with the three different scores above mentioned. 144 patients (male 96 aged 68.5 years) were included in the study. 93 patients reported a least 1 comorbidity and 36 died. The association with increasing age, presence of comorbidities, and lower hemoglobin was significantly associated with risk of death for all the regression models. When considering the radiological score, a significant effect was found for the Al Smadi and RALE scores, while no evidence of association was found for the Toussie score. The fraction of new information is 16.7% for the Al Smadi score, 12.9% for the RALE and 5.1% for the Toussie score. The improvement in the prognostic usefulness with respect to the base model is particularly interesting for the Al Smadi score. The highest c-index was also obtained by the model with the Al Smadi score.
在 COVID-19 大流行期间,Al-Smadi 和 Toussie 在这组患者中验证了胸部 X 射线评分系统,甚至以前为 ARDS 设计的 RALE 评分也被用于估计与死亡率的相关性。本研究的目的是评估 Al-Smadi、Tuossie 和 RALE 评分在与临床数据相关联时,对同一患者群体预测死亡的预后价值。在这项回顾性临床研究中,收集了 2020 年 10 月 1 日至 12 月 31 日期间我院收治的 COVID-19 患者的数据。对每个患者的 CXR 图像进行了上述三种不同评分的分析。共纳入 144 例患者(男性 96 例,年龄 68.5 岁)。93 例患者至少有 1 种合并症,36 例死亡。在所有回归模型中,与年龄增加、合并症存在和血红蛋白降低相关的与死亡风险显著相关。考虑到放射评分,Al Smadi 和 RALE 评分有显著影响,而 Toussie 评分无关联证据。Al Smadi 评分的新信息比例为 16.7%, RALE 评分的新信息比例为 12.9%,Toussie 评分的新信息比例为 5.1%。与基础模型相比,Al Smadi 评分的预后有用性的改善特别有趣。Al Smadi 评分模型的最高 c 指数也得到了证明。